Opus Genetics (IRD) Invested Capital (2021 - 2022)
Opus Genetics' (IRD) quarterly Invested Capital came in at $215000.0 in Q1 2022, down 60.04% on a QoQ basis from $538000.0 in Q4 2021.
Opus Genetics (IRD) Invested Capital (2021 - 2022) Analysis & Trends
Opus Genetics (IRD) has 2 years of Invested Capital data on file, last reported at $215000.0 in Q1 2022.
- On a quarterly basis, Invested Capital changed N/A year-over-year to $215000.0 in Q1 2022; TTM through Dec 2022 was $215000.0, a 60.04% decrease from a year earlier, with the FY2021 full-year figure at $538000.0, changed N/A from the prior year.
- Invested Capital for Q1 2022 stood at $215000.0, down from $538000.0 in the prior quarter.
- Over the last five years, Invested Capital for IRD reached as high as $538000.0 in Q4 2021 and fell as low as $215000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 116.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Opus Genetics | 263.72 Mn | 203.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 215,000.00 |
| Dec 31, 2021 | 538,000.00 |